Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
477.00    4.00 (0.85%)
Bid:
476.00
Ask:
477.00
Spread: 1.00 (0.21%)
Market Cap: £787.12m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

TR1

7 Feb 2008 14:36

Oakley Capital Investments Limited07 February 2008 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES s 1. Identity of the issuer or the underlying issuer of existing Oakley Capital Investments Limitedshares to which voting rights are attached(ii): 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments which may result in the acquisition ofshares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the notification obligation HBOS plc(iii): 4. Full name of shareholder(s) (if different from 3.)(iv): See Section 9. 5. Date of the transaction (and date on which the threshold is 31 January 2008crossed or reached if different)(v): 6. Date on which issuer notified: 1 February 2008 7. Threshold(s) that is/are crossed or reached: Increase to above 3% of Direct Holdings 8. Notified details: A: Voting rights attached to sharesClass/type of Situation previous to Resulting situation after the triggering transaction(vii)shares the Triggering transaction (vi) if possible Number of Number of Number of Number of voting rights % of voting rightsusing the ISIN Shares Voting shares ixCODE Rights viii Direct Direct x Indirect xi Direct Indirect Ord 1p Shares N/A N/A 3,109,938 3,109,938 N/A 3.110 N/A ISIN BMG670131058 B: Financial InstrumentsResulting situation after the triggering transaction xiiType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument xiii Period/ Date xiv that may be acquired if rights the instrument is exercised/ converted. N/A Total (A+B)Number of voting rights % of voting rights 3,109,938 3.110% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable xv:Clerical Medical Managed Funds Limited* ('CMMFL') - (Direct) - 2,658,363 (2.658%) (* - wholly owned subsidiaries of HBOS plc.) Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: Notification using the total voting rights figure of 100,000,000 14. Contact name: Mark Suchopar 15. Contact telephone number: 020 7766 6900 -------------------------- This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20232:15 pmEQSHardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
15th Dec 20227:00 amRNSOCI commits EUR 30m to Oakley PROfounders III
29th Nov 20227:30 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): Evolution of the high-growth drivers in 2023
10th Nov 20224:17 pmRNSDirector Dealing
10th Nov 20224:15 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading update for the 3 months ended 30 Sep 2022
13th Oct 20227:00 amRNSOakley Capital agrees partial exit from Wishcard
10th Oct 202211:55 amEQSHardman & Co Research : Q&A on Oakley Capital Investments (OCI) | 1H'22 results once again proving NAV is real and resilient
30th Sep 20223:00 pmRNSResult of AGM
20th Sep 20224:00 pmEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 1H’22: results prove NAV real, resilient and growing
8th Sep 20227:00 amRNSInterim results for the 6 months ended 30 June 22
6th Sep 20227:00 amRNSOakley agrees follow-on investment in Facile.it
5th Sep 202212:26 pmRNSOakley Capital invests in vLex
5th Sep 20227:05 amRNSNotice of Annual General Meeting
30th Aug 202212:00 pmRNSOakley Capital invests in Phenna Group & CTS Group
26th Aug 20227:00 amRNSNotice of Results and Investor Presentation
25th Aug 20227:00 amRNSOakley Capital invests in Affinitas Education
8th Aug 20227:00 amRNSTransaction in Own Shares
27th Jul 202210:00 amRNSOakley Capital agrees partial exit from Seedtag
27th Jul 20227:00 amRNSTrading update for the 3 months ended 30 June 2022
26th Jul 20222:00 pmRNSOakley's Grupo Primavera to merge with Cegid
29th Jun 202212:50 pmRNSDirector Dealing
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSOakley Capital agrees sale of Facile.it
10th Jun 202211:05 amEQSHardman & Co Research: Q&A on Oakley Capital Investments: Impressive market and peer-beating 19% NAV CAGR growth 2017-21
8th Jun 20227:00 amRNSSale of Contabo and follow-on investment
16th May 20222:15 pmEQSHardman & Co Research: Oakley Capital Investments (OCI) - Capital Markets Day 2022 – let the sun shine
10th May 20227:00 amRNSDirector Dealing
9th May 20227:00 amRNSTransaction in Own Shares
6th May 20227:00 amRNSInvestment in Vice Golf
5th May 20227:00 amRNSTransaction in Own Shares
4th May 20227:00 amRNSTransaction in Own Shares
3rd May 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTrading update for the 3 months ended 31 March 22
19th Apr 20225:00 pmEQSHardman & Co: Q&A on Oakley Capital Investments Ltd: Proving the pudding: a sustainable growth model'
8th Apr 20221:38 pmRNSHolding(s) in Company
28th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20222:45 pmEQSHardman & Co Research: Oakley Capital Investments Ltd (OCI) - Proving the pudding: a sustainable growth model
14th Mar 20223:04 pmRNSDirector Dealing
11th Mar 20226:17 pmRNSDirector Dealing
11th Mar 20229:08 amRNSResults analysis from Kepler Trust Intelligence
10th Mar 20227:04 amRNSShare Buy-Back Programme
10th Mar 20227:00 amRNSFinal Results for the year ended 31 December 2021
3rd Mar 20227:00 amRNSNotice of Results and Webcast Presentation
9th Feb 20228:30 amEQSHardman & Co Research: Oakley Capital Investments (OCI) Educating on education
31st Jan 202212:52 pmRNSDirector Dealing
31st Jan 202212:51 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.